Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM Patients
Diabetes Care 2023 Mar 01;[EPub Ahead of Print], S Abdelgani, A Khatab, J Adams, M Abu-Farha, G Daniele, F Al-Mulla, S Del Prato, RA DeFronzo, M Abdul-GhaniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.